Breakout, retest, potential triple bottom


Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.
הערה
תמונת-בזק 33 cent limit in case of break down
biopharmabiopharmaceuticalChart PatternsTechnical IndicatorspalatinpennystockspharmaceuticalpharmaceuticalsPTNTECHtechnologyTrend Analysis

כתב ויתור